1. 576 NL-201, a de novo IL-2 and IL-15 agonist, demonstrates enhanced in vivo antitumor activity in combination with multiple cancer immunotherapies. (9th November 2020) Authors: Walkey, Carl; Swanson, Ryan; Ulge, Umut; Silva Manzano, Daniel Adriano; Drachman, Jonathan Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗